Notice of Postal Ballot
Sun Pharmaceutical Industries Ltd has submitted to BSE a Copy of the Notice of Postal Ballot.06-10-2015
06-10-2015
Sun Pharma settles US patent litigation with Actavis over skin care drug
Ranbaxy, Cipher and Galephar enter into a non-exclusive license agreement with Actavis05-10-2015
Sun Pharma announces Absorica patent litigation settlement
Sun Pharmaceutical Industries Ltd has informed BSE regarding a Press Release dated October 05, 2015 titled "Sun Pharma announces Absorica patent litigation settlement".05-10-2015
Fixes Book Closure for Dividend & AGM
Sun Pharmaceutical Industries Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from October 24, 2015 to October 31, 2015 (both days inclusive) for the purpose of Payment of Dividend & 23rd Annual General Meeting (AGM) of the Company to be held on October 31, 2015.05-10-2015
Sun Pharma spurts 2.6% on BSE
Pharma and IT shares were in the limelight on the BSE on Thursday. At 11.39 am Sun Pharma led the pack on the bourse trading at Rs 891.10 against Rs 868.45 at close yesterday. This was a gain of 2...01-10-2015
Sun Pharma starts tender offer for InSite Vision buyout
Thea Acquisition Corp. has offered $0.35 a share, without interest and less any required withholding taxes to InSite Vision29-09-2015
Sun Pharma commences Tender Offer for Acquisition of InSite Vision
Sun Pharmaceutical Industries Ltd has informed BSE regarding a Press Release dated September 29, 2015 titled "Sun Pharma commences Tender Offer for Acquisition of InSite Vision".29-09-2015
Sun Pharma and Sparc: Fall in shares justified?
Sun Pharma shares fell 3.42%, while Sparcs shed 2.62% on Monday after the group research firm said FDA withdrew approval for epilepsy drug Elepsia XR28-09-2015
FDA revokes approval for Sun Pharma's epilepsy drug
Sun Pharma says US FDA revoked the approval citing manufacturing quality issues at its production site26-09-2015
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Jayant S Sanghvi has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE26-09-2015